Thryv Therapeutics is developing therapies for genetic heart diseases pioneering a precision medicine approach to treat patients with Long QT Syndrome and potentially other arrhythmias.
Location: Canada, Quebec, Laval
Employees: 11-50
Total raised: $19M
Founded date: 2019
Investors 2
Date | Name | Website |
08.11.2021 | Lumira Ven... | lumiravent... |
- | Amzak Heal... | amzakhealt... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
10.08.2021 | Series A | $19M | - | prnewswire... |
Mentions in press and media 8
Date | Title | Description | Source |
06.01.2022 | LQT Therapeutics Announces Award by the European Joint Progr... | Closing the gap between industry and academia to place patients directly at the center of research e... | lumiravent... |
01.11.2021 | LQT Therapeutics Announces the Appointment of Dr. Robert Boo... | Company Strategically Strengthens its Fight Against Long QT Syndrome with Novel Kinase Drug Developm... | lumiravent... |
10.08.2021 | LQT Therapeutics Announces Closing of US$19M Series A Financ... | - Company established with world-class research from leading academia and industry leaders- Lead p... | prnewswire... |
10.08.2021 | LQT Therapeutics secures $19M to tackle heart diseases with ... | LQT Therapeutics wants to tackle debilitating heart arrhythmias with limited interventions, and inve... | fiercebiot... |
10.08.2021 | Lumira Ventures invests in LQT Therapeutics US$19M Series A ... | LQT Therapeutics, Inc. (LQTT) a pharmaceutical company pioneering the development of precision thera... | lumiravent... |
10.08.2021 | LQT Therapeutics secures $19M to tackle heart diseases with ... | LQT Therapeutics wants to tackle debilitating heart arrhythmias with limited interventions, and inve... | fiercebiot... |
09.08.2021 | LQT Therapeutics Announces Closing of US$19M Series A Financ... | - | amzakhealt... |
- | LQT Therapeutics | “Thryv Therapeutics (previously LQT Therapeutics), has been pioneering a precision medicine approach... | fastfounde... |